‘New to me’: changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well®patient materials mixed‐methods feasibility study
Authors:
- P.A. NelsonPNP.A. Nelson
- C. BundyCBC. Bundy
- R. ThorneloeRTR. Thorneloe
- L. CordingleyLCL. Cordingley
- the Identification and Management of Psoriasis‐Associated Co morbidiTy (IMPACT) teamTTthe Identification and Management of Psoriasis‐Associated Co morbidiTy (IMPACT) team
Open Access
- 12 April 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 177 (3) , 758-770
Abstract
Background Psoriasis is an inflammatory long‐term condition involving comorbidities, unhealthy lifestyle and significant life impact. Patients’ understanding of psoriasis is limited and support lacking. The Common‐Sense Model of Self‐Regulation of Health and Illness emphasizes the role of illness and treatment beliefs on coping and self‐management. New ‘Pso Well®’ patient materials informed by the model, addressed psoriasis as a long‐term condition, medication management and lifestyle behaviours. Objectives To investigate whether Pso Well® materials (i) broaden understanding of psoriasis without increasing anxiety; (ii) are acceptable; and (iii) comprise features that appear to effect change. Methods The Revised Illness Perceptions Questionnaire (IPQ‐R modified) and the Hospital Anxiety and Depression Scale (HADS) were administered in patients before and after intervention. Numerical rating scales assessed perceptions of change in understanding and anxiety resulting from engagement with the materials. Qualitative interviews explored acceptability and perceived ‘active ingredients’. Results Fifty‐five patients completed pre‐ and postintervention questionnaires (56% female; median age 59 years). Postintervention, a large effect size was indicated in two IPQ‐R domains – illness coherence [t(55) = −3·48, P = 0·001 (two‐tailed), η2 = 0·19] and personal control [t(55) = −2·98, P = 0·004 (two‐tailed), η2 = 0·14] – and a medium effect in one, treatment control [t(55) = −2·08, P = 0·042 (two‐tailed), η2 = 0·08]. HADS scores did not change. For numerical rating scales, 80% of participants reported increased understanding of psoriasis and none reported increased anxiety. Interviews with 19 patients indicated the materials were acceptable and usable. Factors reported to broaden understanding and promote engagement with self‐management included linking of related disease aspects, personally relevant content and high‐quality design. Conclusions High‐quality, theory‐based psoriasis materials are acceptable to patients and can improve understanding and sense of control without increasing anxiety.Keywords
Funding Information
- National Institute for Health Research (RP‐PG‐0608‐10163)
This publication has 73 references indexed in Scilit:
- ‘On the surface’: a qualitative study of GPs’ and patients’ perspectives on psoriasisBMC Family Practice, 2013
- Depression Severity, Diet Quality, and Physical Activity in Women with Obesity and DepressionJournal of the Academy of Nutrition and Dietetics, 2012
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- The Risk of Depression, Anxiety, and Suicidality in Patients With PsoriasisArchives of Dermatology, 2010
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research DatabaseEuropean Heart Journal, 2009
- Developing and evaluating complex interventions: the new Medical Research Council guidanceBMJ, 2008
- Smoking and the Risk of Psoriasis in Women: Nurses’ Health Study IIThe American Journal of Medicine, 2007
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchives of Dermatological Research, 2006
- Illness cognition: Using common sense to understand treatment adherence and affect cognition interactionsCognitive Therapy and Research, 1992
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983